These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 7684865

  • 1. Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: results of a randomized controlled trial.
    Porter AT, McEwan AJ.
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):38-43. PubMed ID: 7684865
    [Abstract] [Full Text] [Related]

  • 2. Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group.
    Bolger JJ, Dearnaley DP, Kirk D, Lewington VJ, Mason MD, Quilty PM, Reed NS, Russell JM, Yardley J.
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):32-3. PubMed ID: 7684863
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial.
    Sciuto R, Festa A, Rea S, Pasqualoni R, Bergomi S, Petrilli G, Maini CL.
    J Nucl Med; 2002 Jan; 43(1):79-86. PubMed ID: 11801708
    [Abstract] [Full Text] [Related]

  • 6. Palliation of bone pain in patients with metastatic cancer using strontium-89 (Metastron).
    Kan MK.
    Cancer Nurs; 1995 Aug; 18(4):286-91. PubMed ID: 7545083
    [Abstract] [Full Text] [Related]

  • 7. [Effectiveness of repeated systematic radiotherapy for generalized prostate cancer].
    Kiselev EN, Korytova LI, Karelin MI.
    Vopr Onkol; 2005 Aug; 51(6):689-91. PubMed ID: 17037036
    [Abstract] [Full Text] [Related]

  • 8. Systemic radionuclide therapy of bone metastases with strontium-89.
    Porter AT, Davis LP.
    Oncology (Williston Park); 1994 Feb; 8(2):93-6; discussion 96, 99-101. PubMed ID: 8167090
    [Abstract] [Full Text] [Related]

  • 9. Bone pain palliation with 85Sr therapy.
    Giammarile F, Mognetti T, Blondet C, Desuzinges C, Chauvot P.
    J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
    [Abstract] [Full Text] [Related]

  • 10. Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy.
    Malmberg I, Persson U, Ask A, Tennvall J, Abrahamsson PA.
    Urology; 1997 Nov; 50(5):747-53. PubMed ID: 9372886
    [Abstract] [Full Text] [Related]

  • 11. Clinical experience with strontium-89 in prostatic and breast cancer patients.
    Robinson RG, Preston DF, Baxter KG, Dusing RW, Spicer JA.
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):44-8. PubMed ID: 8503027
    [Abstract] [Full Text] [Related]

  • 12. External beam radiotherapy in bone metastatic prostate cancer: impact on patients' pain relief and quality of life.
    Di Lorenzo G, Autorino R, Ciardiello F, Raben D, Bianco C, Troiani T, Pizza C, De Laurentiis M, Pensabene M, D'Armiento M, Bianco AR, De Placido S.
    Oncol Rep; 2003 Jun; 10(2):399-404. PubMed ID: 12579279
    [Abstract] [Full Text] [Related]

  • 13. Strontium-89 (Metastron) in the treatment of prostate cancer metastatic to bone.
    Porter AT.
    Eur Urol; 1994 Jun; 26 Suppl 1():20-5. PubMed ID: 7537665
    [Abstract] [Full Text] [Related]

  • 14. Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy.
    Tu SM, Kim J, Pagliaro LC, Vakar-Lopez F, Wong FC, Wen S, General R, Podoloff DA, Lin SH, Logothetis CJ.
    J Clin Oncol; 2005 Nov 01; 23(31):7904-10. PubMed ID: 16258090
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Strontium-89 for treatment of painful bone metastasis from prostate cancer.
    Altman GB, Lee CA.
    Oncol Nurs Forum; 1996 Apr 01; 23(3):523-7. PubMed ID: 8801513
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Strontium-89 for bone metastases from prostate cancer: an update].
    Zhao WW, Xie P, Deng HF.
    Zhonghua Nan Ke Xue; 2010 Mar 01; 16(3):269-72. PubMed ID: 20369560
    [Abstract] [Full Text] [Related]

  • 19. A retrospective analysis of the cost effectiveness of treatment with Metastron in patients with prostate cancer metastatic to bone.
    McEwan AJ, Amyotte GA, McGowan DG, MacGillivray JA, Porter AT.
    Eur Urol; 1994 Mar 01; 26 Suppl 1():26-31. PubMed ID: 7537666
    [Abstract] [Full Text] [Related]

  • 20. [The efficacy of therapy using 89Sr-strontium chloride in 200 patients with bone metastases of a prostatic cancer].
    Haesner M, Buchali K, Pink V, Lips H.
    Nuklearmedizin; 1992 Mar 01; 31(2):48-52. PubMed ID: 1373485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.